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Objectives This study sought to assess the mortality risk of patients with coronary artery disease (CAD) based on a combi-
nation of body mass index (BMI) and measures of central obesity.
Background In CAD patients, mortality has been reported to vary inversely with BMI (“obesity paradox”). In contrast, central
obesity is directly associated with mortality. Because of this bi-directional relationship, we hypothesized that CAD
patients with normal BMI but with central obesity would have worse survival compared with subjects with other
combinations of BMI and central adiposity.
Methods We included 15,547 participants with CAD who took part in 5 studies from 3 continents. Multivariate stratified
Cox-proportional hazard models that adjusted for potential confounders were used to assess mortality risk
according to different patterns of adiposity that combined BMI with measures of central obesity.
Results Mean age was 66 years; 55% were men. There were 4,699 deaths over a median follow-up of 4.7 years. Sub-
jects with normal weight but central obesity had the worst long-term survival: a person with BMI of 22 kg/m2
and waist-to-hip ratio (WHR) of 0.98 had higher mortality than a person with similar BMI but WHR of 0.89 (haz-
ard ratio [HR]: 1.10; 95% confidence interval [CI]: 1.05 to 1.17); than a person with BMI of 26 kg/m2 and WHR
of 0.89 (HR: 1.20; 95% CI: 1.09 to 1.31), than in a person with BMI of 30 kg/m2 and WHR of 0.89 (HR: 1.61;
95% CI: 1.39 to 1.86), and than a person with BMI of 30 kg/m2 and WHR of 0.98 (HR: 1.27; 95% CI: 1.18 to
1.39) (p  0.0001 for all).
Conclusions In patients with CAD, normal weight with central obesity was associated with the highest risk of mortality. (J Am
Coll Cardiol 2013;61:553–60) © 2013 by the American College of Cardiology Foundation
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Normal Weight Central Obesity and Mortality in CAD February 5, 2013:553–60Over the last decade, attention
has been directed to the prognos-
tic value of obesity, as defined by
the body mass index (BMI),
among subjects with coronary ar-
tery disease (CAD). Despite the
fact that obesity has been associ-
ated with higher prevalence of
cardiovascular risk factors and
cardiovascular disease (1), several
publications have shown BMI to
be inversely associated with mor-
tality in patients with CAD (the so-called “obesity para-
dox”) (2). Such findings challenge conventional wisdom,
because obesity is known to be associated with diabetes,
hypertension, and dyslipidemia (3); and the majority of
subjects with CAD are either overweight or obese (4).
Because BMI has been shown to be a poor discriminator of
body fat and lean mass, especially in CAD patients (5), the
entity of “normal weight obesity” (i.e., normal BMI but
high body fat content) has been recently described and
shown to be associated with cardiovascular risk factors, and
also with increased mortality in women (6). In addition, we
have recently demonstrated that measures of fat distribu-
tion, such as the waist circumference (WC) and waist-
to-hip ratio (WHR), are directly associated with mortal-
ity in people with CAD (7), in contrast to BMI.
However, what remains poorly defined is whether the
combination of BMI with measures of central obesity can
help better discriminate CAD patients at greater mortal-
ity risk, and how patients with normal BMI but who are
centrally obese fare in comparison to patients with other
body adiposity patterns.
Thus, we hypothesized that patients with CAD with
normal BMI but who have central obesity would have worse
long-term survival compared with subjects with normal,
overweight and obese BMI who do not have central obesity.
To this end, we sought to investigate the mortality risk
associated with patterns of body adiposity based on a
combination of BMI and either WC or WHR in a large,
multiethnic sample of patients with CAD.
Methods
Subjects. Through a systematic review of the literature and
ollaborative effort to assess the prognostic value of central
besity in CAD, we created a large database comprising
5,923 subjects with CAD from 3 different continents,
etails regarding the systematic review, inclusion and ex-
lusion criteria, origin of the cohorts included, and approach
Dr. Lopez-Jimenez has performed research partially sponsored by Select Research, to
assess the clinical value to measure body volumes with a three-dimensional scanner.
All other authors have reported they have no relationships relevant to the contents of
this paper to disclose.
Abbreviations
and Acronyms
BMI  body mass index
CAD  coronary artery
disease
CI  confidence interval
HR  hazard ratio
WC  waist circumference
WHR  waist-to-hip ratioo
Manuscript received September 6, 2012; revised manuscript received October 16,
2012, accepted October 28, 2012.to obtain individual-level data have been previously pub-
lished (7). In summary, we identified 6 studies that assessed
risk of mortality associated with either WC or WHR in
CAD patients from 1980 to 2008. Four of these studies
agreed to share individual-level data, and then we further
pooled unpublished data from the Mayo Clinic Cardiovas-
cular Rehabilitation database, yielding our final study sam-
ple. Because there is no controversy surrounding the in-
creased mortality observed in extremely thin individuals (2),
resumably due to higher prevalence of chronic diseases and
erminal conditions that affect prognosis, we excluded 373
nderweight subjects (BMI 18.5 kg/m2). We also ex-
luded 3 participants with erroneous anthropometric
easurements.
atterns of adiposity. It was hypothesized that among
atients with CAD a combination of normal BMI and
entral obesity would result in a higher risk of mortality
ompared with other patterns of adiposity. BMI was calcu-
ated by dividing weight (in kilograms) by the square of
eight (meters). Central obesity was quantified using either
C or WHR. WC was available for subjects from 4 studies
8–11), and WHR was available for subjects in 3 studies
9–11). BMI was available for all subjects.
tatistical modeling. The overarching goal of the analysis
as to develop a parsimonious Cox model to quantify the
elative hazard of mortality based on comparisons of com-
inations of body mass and measures of central obesity.
Stratified Cox models were estimated using each study as
he stratification factor (i.e., the model allowed for each
tudy to have its own background hazard rate while esti-
ating common hazard ratios [HRs] for variables included
n the model). Higher order interactions of WHR or WC
ith BMI were considered to allow for nonlinear relation-
hips in the risk for various combinations of values for these
ariables. Likewise, interactions between the measures of
diposity with sex were also tested. Likelihood ratio tests
ere used to determine if these higher order model terms
ould be removed. Once the final model was established,
Rs were estimated for different profiles of participants
represented as candidate persons with different body adi-
osity patterns that combine BMI with a measure of central
besity) using the estimated model parameters. For these
omparisons, we chose a BMI of 22 kg/m2 to represent
“normal BMI,” 26 kg/m2 to represent “overweight BMI,”
and 30 kg/m2 to represent “obese BMI.” For WC and
HR, we chose the values that represented the 25th and
5th percentiles of the sample. For WC, these values were
5 and 101 cm, respectively; for WHR, these values were
.89 and 0.98, respectively. HRs and their estimated SEs
ere used to conduct Wald (or large sample) tests for
tatistical significance between the representative patient
rofiles. These estimates were adjusted for age, sex, history
f smoking, and the presence of hypertension, diabetes, and
eart failure. These adjustment variables have been shown
o predict survival in patients with CAD (12). Inclusion of
ther putative confounding variables was hindered due to
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February 5, 2013:553–60 Normal Weight Central Obesity and Mortality in CADunavailability of data across all studies. The proportional
hazards assumption for WC, WHR, and BMI was assessed
and was satisfied for the final models.
The robustness of the modeling framework was tested by
replacing the continuous measures of central obesity and
BMI by a set of indicator variables representing different
groups of patients based on BMI and WC or WHR.
Because this method of testing for association is less
powerful (13), these models were used to qualitatively assess
the magnitude of associations observed in the more complex
Cox models. These results from the analysis using the
categorized variables agreed with the estimates obtained
using the continuous variable representation.
Modeling was supported through standard descriptive
statistics of the sample data. Continuous variables were
reported as mean  SD, and categorical variables were
reported as percentages. Statistical analyses were performed
using JMP version 9.0.1 (SAS Institute Inc., Cary, North
Carolina) and the SAS System version 9.3 (SAS Institute
Inc.).
Results
Mean age of the subjects was 65.5  11.5 years, and 60%
were men. There were 5,507 deaths over a median
follow-up of 2.4 years (interquartile range 0.5 to 7.4 years).
The remaining baseline characteristics of the participants
are outlined in Table 1.
The interaction term analyses showed that there was a
significant interaction between BMI and WC or WHR
(p  0.001). Interactions between sex and BMI, sex and
WC, and sex and WHR were not statistically significant
(p  0.05 for all). The crude death risk based on different
combinations of BMI with central obesity can be seen in
Baseline Characteristics of ParticipantsTable 1 Baseline Characteristics of Particip
Whol
(n 
Age (yrs) 65.6
Height (cm) 166.
Weight (kg) 73.6
Body mass index (kg/m2) 26.3
Waist circumference (cm) (n  13,935) 93.4
Hip circumference (cm) (n  12,525) 98.6
Waist-to-hip ratio (n  12,525) 0.93
History of hypertension 6,01
History of diabetes 2,88
History of smoking 9,61
History of heart failure 2,12
Serum creatinine (mol/l) (n  12,251)*† 94.6 (7
Aspirin use (n  12,312) 9,64
Beta blocker use (n  12,316) 3,81
ACEi/ARB use (n  12,316) 3,48
Deaths 5,50
Values are mean  SD, n (%), or median (interquartile range). *Ser
skewness of its distribution. †To convert serum creatinine to milligramACEi  angiotensin-converting enzyme inhibitor; ARB  angiotensin recep
waist circumference; WHR  waist-to-hip ratio.Figure 1 (WC) and Figure 2 (WHR). Examination of
Figures 1 and 2 reveals that subjects who have a normal
BMI but are in the highest quintiles of central obesity have
higher mortality risk than any other combination of BMI
and central obesity. Conversely, subjects who had a BMI in
the overweight or obese categories but were in the lowest
quintiles of central obesity had the lowest mortality. Similar
findings were observed when using WC or WHR as the
measure of central obesity.
The final multivariate stratified Cox model is depicted in
Table 2. Based on the results from this model, we estimated
the HRs for mortality attributed to patients with normal
weight central obesity compared with subjects with other
patterns of adiposity. Results are illustrated in Figure 3
(using WC) and Figure 4 (using WHR), and show that
subjects with normal weight central obesity (“Person 2” in
Figs. 3 and 4) have higher mortality than subjects with any
other combination of BMI with WC or WHR. Specifi-
cally, a person with normal weight central obesity had
10% to 17% higher mortality risk than a person with
similar BMI but no central obesity, 20% to 31% higher
risk of mortality than an overweight subject without
central obesity, 57% to 61% greater mortality than an
obese person without central obesity, and 27% to 44%
higher risk of dying than an obese subject with similar
WC or WHR. Together, the results depicted in Figures
1 to 4 confirm that subjects with CAD who have a BMI
in the normal range but are centrally obese have the worst
prognosis. Results were similar when a BMI of 23.5
kg/m2 was chosen instead of 22 kg/m2 to represent
normal BMI in the groups (analyses not shown).
Lastly, we found that although increasing age attenuated
the effects of normal weight central obesity on mortality,
p
7)
Women
(n  6,286)
Men
(n  9,261)
5 69.0 9.6 63.2 12.1
2 159.5 6.7 171.9 7.0
4 68.3 14.4 77.2 13.3
26.8 5.2 26.0 3.7
5 91.5 13.5 94.9 11.5
8 101.1 12.6 96.6 8.6
8 0.90 0.08 0.96 0.06
) 3,130 (50%) 2,886 (31%)
) 1,376 (22%) 1,512 (16%)
) 3,117 (50%) 6,495 (70%)
) 934 (15%) 1,192 (13%)
8.4) 88.4 (79.6–106.8) 97.2 (84.0–114.0)
) 4,197 (76%) 5,443 (80%)
) 1,665 (30%) 2,146 (32%)
) 1,235 (22%) 2,246 (33%)
) 2,127 (35.5%) 3,380 (44.1%)
tinine was reported as median (interquartile range) because of the
deciliter, divide by 88.4.ants
e Grou
15,54
 11.
1 9.
 14.
 4.4
 12.
 10.
 0.0
6 (39%
8 (19%
2 (62%
6 (14%
9.6–10
0 (78%
1 (31%
1 (28%
7 (35%
um crea
s pertor blocker. BMI  body mass index; IQR interquartile range; WC 
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Normal Weight Central Obesity and Mortality in CAD February 5, 2013:553–60this association remained statistically significant across dif-
ferent age groups (data not shown).
Discussion
In a large cohort of subjects with CAD from 3 different
continents and with different manifestations of CAD, we
have shown that subjects with normal weight central obesity
have the worst long-term survival compared with subjects
with other adiposity patterns. Furthermore, we have dem-
onstrated that being overweight or obese by BMI criteria
does not lead to higher mortality in the absence of central
obesity. Our findings support the concept that clinicians
should go beyond BMI when assessing mortality risk in
patients with CAD, because combining BMI with measures
of central obesity allows us to better discriminate those at
the highest and lowest risk of dying.
Central obesity has been shown to be a predictor of
mortality in the general population (14,15) and among
patients with CAD (8,9,11). In the general population,
BMI in the overweight and obese ranges was associated
with higher overall mortality (16). In contrast, when BMI
was used as a measure of adiposity in CAD patients, higher
BMI was associated with lower mortality (2), which has
been named “the obesity paradox.” The divergent associa-
Figure 1
5-Year Mortality in Patients With
Coronary Artery Disease Based on Different
Combinations of Body Mass Index With
Central Obesity (Waist Circumference)
Categories of body mass index (BMI) are depicted in the X axis. “Normal BMI”
was divided into 2 categories: 18.5 to 21.9 and 22 to 24.9 kg/m2. BMI of 25
to 29.9 kg/m2 represents the overweight, and BMI 30 kg/m2 represents the
obese. In the Z axis, patients were categorized into quintiles of waist circum-
ference. The Y axis depicts the mortality associated with each combination of
BMI with central obesity.tions of central obesity and BMI with mortality in CADpatients were the basis for the present study. Although we
have previously compared and contrasted the independent
prognostic value attributed to central obesity and to BMI in
patients with CAD (7), the present study further adds to the
literature by assessing the additive prognostic information
obtained by combining BMI with WC or WHR, and by
comparing the prognostic implications of normal weight
central obesity relative to other combinations of body
adiposity, including subjects with overweight and obesity by
BMI but without central obesity.
Although this is the first study to primarily focus on the
assessment of mortality in patients with CAD based on
combined assessment of BMI and central obesity, secondary
analyses from 3 previous studies (8,11,17) also assessed the
prognosis associated with body adiposity patterns in CAD
patients, yielding preliminary results. However, the meth-
odologies of these studies were significantly different from
our study. In a substudy of patients with acute coronary
syndromes from the MERLIN–TIMI 36 (Metabolic Effi-
ciency With Ranolazine for Less Ischemia in NSTE-ACS–
Thrombolysis In Myocardial Infarction 36) trial (17), only
WC was used, and underweight patients were grouped
together with normal BMI patients, potentially increasing
the mortality of the reference group. In that study, normal
weight central obesity showed a trend toward an association
with cardiovascular events after adjustment for confounders,
Figure 2
5-Year Mortality in Patients With Coronary Artery Dis-
ease Based on Different Combinations of Body Mass
Index With Central Obesity (Waist-to-Hip Ratio)
In the Z axis, patients were categorized into quintiles of waist-to-hip ratio.
Legends for the X and Y axis are the same as in Figure 1.
timate
ist-to-hi
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February 5, 2013:553–60 Normal Weight Central Obesity and Mortality in CADbut it was not statistically significant. In a study of Korean
patients with myocardial infarction (11), normal weight central
obesity was not significantly associated with increased mortality
using WHR as the measure of central obesity. In addition, in
a study of post-menopausal women with CAD (8), normal
weight central obesity (defined by WC) was associated with
increased mortality after adjustment for age only. Furthermore,
in the INTERHEART study, a multinational case-control
study of risk factors for first myocardial infarction (18),
Final Cox Proportional Hazards Models for the WC and WHR RatioTable 2 Final Cox Proportional Hazards Models for the WC and
WC Model
HR 95% CI Parameter Estimates
Age 1.06 1.06–1.07 0.06
Male 1.18 1.10–1.27 0.17
Smoking 1.10 1.03–1.17 0.09
Hypertension 1.23 1.16–1.31 0.21
Diabetes 1.59 1.47–1.72 0.46
CHF 2.03 1.89–2.18 0.71
BMI 0.97 0.96–0.98 0.03
WC 1.01 1.00–1.01 0.007
WHR — — —
BMI  WC interaction 1.00 1.00–1.00 0.001
BMI  WHR interaction —
BMI  BMI —
Two separate Cox regression models were fit. In the model including WC, all model parameters wer
(p  0.001). The model with waist-to-hip (WHR) also was statistically significant (chi-square  2,
p  0.001 except for the interaction term of body mass index (BMI) with WHR. This parameter es
CHF  coronary heart failure; CI  confidence interval; WC  waist circumference; WHR  wa
Figure 3 Mortality Risk of Subjects With Normal Weight Centra
With Other Patterns of Adiposity, Using Waist Circum
A body mass index (BMI) of 22 kg/m2 was chosen to represent normal BMI, 26 k
Measures of waist circumference (WC) were chosen to represent the 25th (85 cm
dence interval; HR  hazards ratio.WC and WHR were also found to be predictors of first
myocardial infarction even in normal BMI ranges. How-
ever, INTERHEART was not designed to assess risk
among those with established CAD, and mortality data
were not available. In contrast, Lavie et al. (19) showed
that CAD patients with low body fat percentage had
higher 3-year mortality than those with high body fat
percentage, and in a separate study, also showed that
CAD patients with normal BMI and high body fat, and
ctorsRatio Predictors
WHR Model
SE HR 95% CI Parameter Estimate SE
0.002 1.06 1.06–1.07 0.06 0.002
0.03 1.14 1.06–1.22 0.13 0.04
0.03 1.12 1.04–1.19 0.11 0.03
0.03 1.24 1.16–1.32 0.21 0.03
0.04 1.63 1.50–1.76 0.49 0.04
0.04 1.94 1.80–2.09 0.66 0.04
0.006 0.97 0.96–0.98 0.03 0.005
0.002 — — — —
— 4.25 2.84–6.36 1.45 0.20
0.0002 — — — —
— 1.09 1.00–1.18 0.08 0.04
— 1.00 1.00–1.00 0.002 0.0004
tically significant with p 0.001. The overall model chi-square was 2,636 on 9 degrees of freedom
10 degrees of freedom, p  0.001). Each estimated parameter was statistically significant with
’s p value was 0.038. Hazard ratios (HRs) are presented as a 1-unit increase in the variables.
p ratio.
esity Compared With Subjects
ce as a Measure of Central Obesity
as chosen to represent overweight BMI, and 30 kg/m2 represents obese BMI.
5th (101 cm) percentiles of the distribution of WC in the sample. CI  confi-PrediWHR
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Normal Weight Central Obesity and Mortality in CAD February 5, 2013:553–60with high BMI and low body fat did not differ with
respect to survival (20). These results contrast with our
findings, probably because body fat percentage was mea-
sured by a simplified method (sum of skinfolds), which
assessed subcutaneous fat but not visceral fat, and like
BMI, it is also related to total body fat but gives no
insight into fat distribution. In addition, contrasting
results were also found in a large study of patients with
heart failure with reduced ejection fraction (21), where
men (but not women) with high WC had lower event-
free survival than men with normal WC. However, due to
the composite endpoint of the study, we could not
directly infer the association of WC with mortality in
that cohort.
Given the high prevalence of obesity and its associated
comorbidities in the United States, the American Heart
Association recently released a Scientific Statement regard-
ing the assessment of adiposity (22). Our novel findings
help redefine our practice regarding obesity in patients with
CAD, because these results emphasize the need to utilize
BMI in combination with measures of central obesity to
improve stratification of mortality risk. Furthermore, our
results highlight those with normal weight central obesity,
whose adiposity-related risk may go unnoticed during clin-
ical assessments due to their normal BMI, as a group that
may require greater attention toward risk stratification and
modification from the medical community. By restricting
the anthropometric assessment to BMI, healthcare provid-
Figure 4 Mortality Risk of Subjects With Normal Weight Centra
With Other Patterns of Adiposity, Using Waist-to-Hip R
A body mass index (BMI) of 22 kg/m2 was chosen to represent normal BMI, 26 k
Measures of waist-to-hip ratio (WHR) were chosen to represent the 25th (0.89) an
Figure 3.ers could miss the opportunity to identify and counsel those owith normal weight central obesity, whom our data identify
as those at highest risk of death. This is an important point,
because physician diagnosis of obesity almost triples the
odds of achieving successful weight loss among subjects
with CAD (23). Although aerobic exercise has been shown
to decrease visceral fat (24), further prospective studies are
needed to establish the optimal lifestyle and therapeutic
interventions to improve the prognosis of CAD patients
with normal weight central obesity.
There are several possible explanations for our findings.
First, central obesity is associated with greater amounts of
visceral fat, which is implicated in the pathogenesis of
hypertension, inflammation, and insulin resistance (25). In
ontrast, BMI has been demonstrated to have a suboptimal
orrelation with body fat, particularly in patients with CAD
5), which may indicate that some CAD patients with high
MI but without central obesity may have preserved muscle
ass rather than increased adiposity. Additionally, normal
eight centrally obese subjects may have sarcopenia, a
ondition linked to poor functional capacity (26) and worse
etabolic profile (27). Patients with low lean mass index
nd low body fat percentage have been found to have the
ighest mortality among those with stable CAD (28). This
lso raises the issue of residual confounding, because normal
eight subjects from the current era may have some of the
ame comorbidities that have been thought to contribute to
igher mortality risk in the underweight (29), although this
emains a controversial topic. Alternatively, large amounts
esity Compared With Subjects
as a Measure of Central Obesity
as chosen to represent overweight BMI, and 30 kg/m2 represents obese BMI.
(0.98) percentiles of the distribution of WHR in the sample. Abbreviations as inl Ob
atio
g/m2 w
d 75thf subcutaneous fat located in the hips and legs, which are
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February 5, 2013:553–60 Normal Weight Central Obesity and Mortality in CADlikely reflected in BMI estimates, have been linked to
healthy metabolic profiles that may be manifested in CAD
patients with lower mortality (30). The higher mortality risk
observed in normal weight, centrally obese patients could
also be explained by less aggressive risk reduction because
these patients may be less likely to receive recommendations
for a healthy diet, exercise, cardiac rehabilitation, or high
doses of preventive medications than their overweight or
obese counterparts. Lastly, previous studies suggest that
subjects who have a normal BMI but low fitness level have
the highest mortality risk (31,32), whereas Sui et al. (33)
demonstrate that patients with high WC have decreased
cardiorespiratory fitness. Thus, it is possible that lower
fitness level among patients with normal weight central
obesity may account for the increased risk of death observed
in our study. A recent study by McAuley et al. (34) again
demonstrates the obesity paradox when BMI is used, while
also showing that CAD patients with WC in the second
tertile have the lowest mortality. However, these associa-
tions are no longer statistically significant after adjustment
for cardiorespiratory fitness, supporting the concept that low
cardiorespiratory fitness may play a role in the obesity
paradox.
The main strength of the present study is the large,
multiethnic cohort of patients with different manifestations
of CAD from 3 different continents, and the novelty of our
findings. Furthermore, measurements of BMI, WC, and
WHR are simple and universally available, which makes our
results highly applicable to clinical practices worldwide. A
shortcoming of our study is the lack of disease-specific
mortality data, as well as lack of data on fitness level,
comprehensive lipid analysis, and body fat percentage.
However, recent evidence suggests that the presence of risk
factors like dyslipidemia and hypertension does not predict
mortality in patients with CAD (35), and therefore, the lack
of adjustment for these risk factors is unlikely to alter the
results. Also, because our cohort is derived from previously
published studies, we cannot exclude the possibility of
publication bias influencing the results, or control for issues
regarding uniform recording of anthropometric variables.
Finally, our data on ethnicity are not comprehensive enough
to allow race-specific analyses.
Conclusions
Patients with CAD with normal BMI but who are centrally
obese have the highest long-term mortality compared with
other patterns of adiposity. In contrast, having an elevated
BMI in the setting of CAD is not detrimental to survival in
the absence of central obesity. When used alone, BMI is a
misleading anthropometric measurement in patients with
CAD, and although measures of central obesity predict
mortality more reliably than BMI, our findings indicate that
combining BMI and measures of central obesity in the
assessment of mortality risk in CAD patients is superior to
documenting BMI alone, and may redefine current practice.Reprint requests and correspondence: Dr. Francisco Lopez-
Jimenez, Division of Cardiovascular Diseases, Mayo Clinic, 200
First Street SW, Rochester, Minnesota 55905. E-mail:
lopez@mayo.edu
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